ECM
BSX icon

ETrade Capital Management’s Boston Scientific BSX Stock Holding History

ETrade Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.13M Buy
29,635
+2,073
+8% +$79.9K 0.02% 332
2020
Q2 		$968K Sell
27,562
-4,816
-15% -$173K 0.02% 360
2020
Q1 		$1.06M Buy
32,378
+698
+2% +$27.3K 0.03% 283
2019
Q4 		$1.43M Buy
31,680
+654
+2% +$27.4K 0.03% 269
2019
Q3 		$1.26M Sell
31,026
-2,269
-7% -$96.1K 0.03% 292
2019
Q2 		$1.43M Buy
33,295
+2,352
+8% +$90.5K 0.04% 272
2019
Q1 		$1.19M Sell
30,943
-4,234
-12% -$162K 0.03% 293
2018
Q4 		$1.24M Buy
35,177
+12,255
+53% +$444K 0.04% 244
2018
Q3 		$882K Buy
22,922
+4,478
+24% +$156K 0.03% 400
2018
Q2 		$603K Buy
18,444
+3,905
+27% +$118K 0.02% 482
2018
Q1 		$397K Buy
14,539
+4,096
+39% +$111K 0.01% 561
2017
Q4 		$259K Sell
10,443
-5,582
-35% -$154K 0.01% 657
2017
Q3 		$467K Buy
16,025
+5,946
+59% +$164K 0.02% 486
2017
Q2 		$279K Buy
10,079
+171
+2% +$4.54K 0.01% 586
2017
Q1 		$246K Buy
9,908
+345
+4% +$8.39K 0.01% 573
2016
Q4 		$207K Buy
9,563
+3
+0% +$65 0.01% 545
2016
Q3 		$228K Buy
9,560
+791
+9% +$18.9K 0.01% 491
2016
Q2 		$205K Buy
+8,769
New +$190K 0.01% 473

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ETrade Capital Management's BSX Position: Q3 2020 in Review

ETrade Capital Management increased its Boston Scientific (BSX) stake by 7.5% in Q3 2020, buying an estimated $79.9K and bringing the position to 29,635 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #332.

ETrade Capital Management first reported a position in BSX in Q2 2016 and has held it in 18 quarters since. The position peaked at $1.43M in Q4 2019. 844 funds tracked by Wall St. Rank hold BSX as of Q3 2020.

  • ETrade Capital Management held 29,635 shares of Boston Scientific worth $1.13M as of Q3 2020.
  • ETrade Capital Management bought 2,073 Boston Scientific shares in Q3 2020, an estimated $79.9K.
  • Boston Scientific made up 0.02% of ETrade Capital Management's portfolio in Q3 2020, its #332 holding.
  • ETrade Capital Management first reported a position in Boston Scientific in Q2 2016 and has held it in 18 quarters since.
  • ETrade Capital Management's Boston Scientific position peaked at $1.43M in Q4 2019.
  • 844 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.